Published in J Clin Oncol on August 01, 2004
The quality oncology practice initiative: assessing and improving care within the medical oncology practice. J Oncol Pract (2006) 2.40
Burdens on research imposed by institutional review boards: the state of the evidence and its implications for regulatory reform. Milbank Q (2011) 2.29
Comparison of prospective and retrospective indicators of the quality of end-of-life cancer care. J Clin Oncol (2008) 1.70
Selecting high priority quality measures for breast cancer quality improvement. Med Care (2008) 1.70
Medicare's Coverage With Evidence Development: A Policy-Making Tool in Evolution. J Oncol Pract (2007) 1.38
Do variations in provider discussions explain socioeconomic disparities in postmastectomy breast reconstruction? J Am Coll Surg (2008) 1.31
National Collaborative to Improve Oncology Practice: The National Cancer Institute Community Cancer Centers Program Quality Oncology Practice Initiative Experience. J Oncol Pract (2009) 1.26
Toward population-based indicators of quality end-of-life care: testing stakeholder agreement. Cancer (2008) 1.14
Metrics for evaluating patient navigation during cancer diagnosis and treatment: crafting a policy-relevant research agenda for patient navigation in cancer care. Cancer (2011) 1.13
Clinical Practice Guidelines in Oncology: Translating Evidence Into Practice (and back). J Oncol Pract (2005) 1.07
Surgical quality and nodal ultrastaging is associated with long-term disease-free survival in early colorectal cancer: an analysis of 2 international multicenter prospective trials. Ann Surg (2010) 1.03
Variation in physician-patient discussion of breast reconstruction. J Gen Intern Med (2008) 0.98
Development of a patient registry to evaluate hospital admissions related to chemotherapy toxicity in a community cancer center. J Oncol Pract (2005) 0.98
The impact of age on quality measure adherence in colon cancer. J Am Coll Surg (2011) 0.96
Degree of variability in performance on breast cancer quality indicators: findings from the Florida initiative for quality cancer care. J Oncol Pract (2011) 0.96
Measuring quality of care in the treatment of colorectal cancer: the moffitt quality practice initiative. J Oncol Pract (2007) 0.91
Risk groups defined by Recursive Partitioning Analysis of patients with colorectal adenocarcinoma treated with colorectal resection. BMC Med Res Methodol (2012) 0.90
The palliative prognostic score and survival in patients with advanced solid tumors receiving chemotherapy. Support Care Cancer (2007) 0.90
Evaluating the quality of colorectal cancer care in the state of Florida: results from the Florida Initiative for Quality Cancer Care. J Oncol Pract (2012) 0.89
Guideline adherence for early breast cancer before and after introduction of the sentinel node biopsy. Br J Cancer (2005) 0.89
Variation in adherence to external beam radiotherapy quality measures among elderly men with localized prostate cancer. Int J Radiat Oncol Biol Phys (2007) 0.89
State-level cancer quality assessment and research: building and sustaining the data infrastructure. Cancer J (2011) 0.88
Is quality of colorectal cancer care good enough? Core measures development and its application for comparing hospitals in Taiwan. BMC Health Serv Res (2010) 0.87
Partnering with payers for success: quality oncology practice initiative, blue cross blue shield of michigan, and the michigan oncology quality consortium. J Oncol Pract (2009) 0.86
Penetration of recommended procedures for lung cancer staging and management in the United States over 10 years: a quality research in radiation oncology survey. Int J Radiat Oncol Biol Phys (2012) 0.86
Many quality measurements, but few quality measures assessing the quality of breast cancer care in women: a systematic review. BMC Cancer (2006) 0.84
Utility of routine data sources for feedback on the quality of cancer care: an assessment based on clinical practice guidelines. BMC Health Serv Res (2009) 0.83
Quality of care for breast cancer for uninsured women in california under the breast and cervical cancer prevention treatment act. J Clin Oncol (2010) 0.82
Accelerating regulatory progress in multi-institutional research. EGEMS (Wash DC) (2014) 0.82
Florida Initiative for Quality Cancer Care: improvements on colorectal cancer quality of care indicators during a 3-year interval. J Am Coll Surg (2013) 0.81
The institutional review board is an impediment to human research: the result is more animal-based research. Philos Ethics Humanit Med (2011) 0.81
Quality indicators of clinical cancer care (QC3) in colorectal cancer. BMJ Open (2013) 0.80
Development and feasibility of a set of quality indicators relative to the timeliness and organisation of care for new breast cancer patients undergoing surgery. BMC Health Serv Res (2012) 0.80
Targeted lymph node evaluation in colorectal cancer: a decade of progress! J Surg Oncol (2009) 0.79
Using population-based registries to study variations in health care. J Oncol Pract (2009) 0.77
Self-reported experience and outcomes of care among stomach cancer patients at a median follow-up time of 27 months from diagnosis. Support Care Cancer (2007) 0.77
Identification of performance indicators across a network of clinical cancer programs. Curr Oncol (2016) 0.75
Improving the quality of cancer care: crossroads or convergence? J Oncol Pract (2009) 0.75
Clinical trial information as a measure of quality cancer care. J Oncol Pract (2010) 0.75
The Affordable Care Act and the future of clinical medicine: the opportunities and challenges. Ann Intern Med (2010) 9.59
Promotion of prescription drugs to consumers. N Engl J Med (2002) 9.21
Early experience with pay-for-performance: from concept to practice. JAMA (2005) 8.98
Risks and benefits of phase 1 oncology trials, 1991 through 2002. N Engl J Med (2005) 8.25
The effect of incentive-based formularies on prescription-drug utilization and spending. N Engl J Med (2003) 7.28
Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol (2004) 7.02
Racial disparities in the quality of care for enrollees in medicare managed care. JAMA (2002) 6.35
Patients' perception of hospital care in the United States. N Engl J Med (2008) 6.10
Care in U.S. hospitals--the Hospital Quality Alliance program. N Engl J Med (2005) 5.74
Paying physicians for high-quality care. N Engl J Med (2004) 5.69
Mortality and access to care among adults after state Medicaid expansions. N Engl J Med (2012) 5.59
Pay for performance in commercial HMOs. N Engl J Med (2006) 5.52
The long-term effect of premier pay for performance on patient outcomes. N Engl J Med (2012) 5.48
Results of the National Initiative for Cancer Care Quality: how can we improve the quality of cancer care in the United States? J Clin Oncol (2006) 5.40
Racial trends in the use of major procedures among the elderly. N Engl J Med (2005) 5.35
Principles for allocation of scarce medical interventions. Lancet (2009) 4.55
Ethical issues concerning research in complementary and alternative medicine. JAMA (2004) 4.48
Public reporting of discharge planning and rates of readmissions. N Engl J Med (2009) 4.43
The obligation to participate in biomedical research. JAMA (2009) 4.34
Volume and outcome--it is time to move ahead. N Engl J Med (2002) 4.26
Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years. J Clin Oncol (2012) 3.63
Descriptions of benefits and risks in consent forms for phase 1 oncology trials. N Engl J Med (2002) 3.62
Physician factors associated with discussions about end-of-life care. Cancer (2010) 3.54
Shared decision making to improve care and reduce costs. N Engl J Med (2013) 3.48
The cost of marginal medicine is too high. MedGenMed (2005) 3.33
What is the concordance between the medical record and patient self-report as data sources for ambulatory care? Med Care (2006) 3.27
Quantifying the federal minimal risk standard: implications for pediatric research without a prospect of direct benefit. JAMA (2005) 3.14
Do integrated medical groups provide higher-quality medical care than individual practice associations? Ann Intern Med (2006) 3.11
The cost of institutional review boards in academic medical centers. N Engl J Med (2005) 3.06
Validity of cancer registry data for measuring the quality of breast cancer care. J Natl Cancer Inst (2002) 3.00
Hospital cost of care, quality of care, and readmission rates: penny wise and pound foolish? Arch Intern Med (2010) 2.89
Prescribing "placebo treatments": results of national survey of US internists and rheumatologists. BMJ (2008) 2.84
Concentration and quality of hospitals that care for elderly black patients. Arch Intern Med (2007) 2.84
Understanding cancer patients' experience and outcomes: development and pilot study of the Cancer Care Outcomes Research and Surveillance patient survey. Support Care Cancer (2006) 2.73
Patients' decision-making process regarding participation in phase I oncology research. J Clin Oncol (2006) 2.72
American Society of Clinical Oncology/National Comprehensive Cancer Network Quality Measures. J Clin Oncol (2008) 2.69
The effect of financial incentives on hospitals that serve poor patients. Ann Intern Med (2010) 2.64
Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity? J Clin Oncol (2008) 2.62
Physicians' beliefs about racial differences in referral for renal transplantation. Am J Kidney Dis (2004) 2.57
The inverse relationship between mortality rates and performance in the Hospital Quality Alliance measures. Health Aff (Millwood) (2007) 2.45
Medicare's requirement for research participation as a condition of coverage: is it ethical? JAMA (2006) 2.43
Research with stored biological samples: what do research participants want? Arch Intern Med (2005) 2.43
The prognosis for changes in end-of-life care after the Schiavo case. Health Aff (Millwood) (2005) 2.40
Paying for performance in the United States and abroad. N Engl J Med (2006) 2.39
Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: a systematic review. Gastroenterology (2002) 2.38
Patients' views on financial conflicts of interest in cancer research trials. N Engl J Med (2006) 2.29
Burdens on research imposed by institutional review boards: the state of the evidence and its implications for regulatory reform. Milbank Q (2011) 2.29
Ethics of phase 1 oncology studies: reexamining the arguments and data. JAMA (2003) 2.28
Representativeness of participants in the cancer care outcomes research and surveillance consortium relative to the surveillance, epidemiology, and end results program. Med Care (2013) 2.22
Uptake and economic impact of first-cycle colony-stimulating factor use during adjuvant treatment of breast cancer. J Clin Oncol (2012) 2.21
Ethical guidance on the use of life-sustaining therapies for patients with Ebola in developed countries. Ann Intern Med (2014) 2.19
US health aid beyond PEPFAR: the Mother & Child Campaign. JAMA (2008) 2.17
Patients' experiences with care for lung cancer and colorectal cancer: findings from the Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol (2010) 2.16
The 50th anniversary of the Declaration of Helsinki: progress but many remaining challenges. JAMA (2013) 2.16
End-of-life care discussions among patients with advanced cancer: a cohort study. Ann Intern Med (2012) 2.08
Comparing patient-reported hospital adverse events with medical record review: do patients know something that hospitals do not? Ann Intern Med (2008) 2.06
Patients' preferences for technical versus interpersonal quality when selecting a primary care physician. Health Serv Res (2005) 2.01
Community permission for medical research in developing countries. Clin Infect Dis (2005) 2.01
Associations between end-of-life discussion characteristics and care received near death: a prospective cohort study. J Clin Oncol (2012) 1.95
Adverse events among the elderly receiving chemotherapy for advanced non-small-cell lung cancer. J Clin Oncol (2009) 1.94
Low-quality, high-cost hospitals, mainly in South, care for sharply higher shares of elderly black, Hispanic, and medicaid patients. Health Aff (Millwood) (2011) 1.91
Adherence to practice guidelines: the role of specialty society guidelines. Am Heart J (2003) 1.91
The standard of care debate: can research in developing countries be both ethical and responsive to those countries' health needs? Am J Public Health (2004) 1.88
The role of primary care physicians in cancer care. J Gen Intern Med (2009) 1.87
A snapshot of smokers after lung and colorectal cancer diagnosis. Cancer (2012) 1.85
Cancer patients' roles in treatment decisions: do characteristics of the decision influence roles? J Clin Oncol (2010) 1.84
Effects of pharmaceutical promotion on adherence to the treatment guidelines for depression. Med Care (2004) 1.84
Health care in America--still too separate, not yet equal. N Engl J Med (2004) 1.84
The patents-based pharmaceutical development process: rationale, problems, and potential reforms. JAMA (2005) 1.83
Patient centered experiences in breast cancer: predicting long-term adherence to tamoxifen use. Med Care (2007) 1.80
The ethics of paying for children's participation in research. J Pediatr (2002) 1.80
What is a "minor" increase over minimal risk? J Pediatr (2005) 1.79
Use of high-cost operative procedures by Medicare beneficiaries enrolled in for-profit and not-for-profit health plans. N Engl J Med (2004) 1.78
Discussions with physicians about hospice among patients with metastatic lung cancer. Arch Intern Med (2009) 1.77
Participants in phase 1 oncology research trials: are they vulnerable? Arch Intern Med (2008) 1.74
Relationship of pulmonary artery catheter use to mortality and resource utilization in patients with severe sepsis. Crit Care Med (2003) 1.72
Ethical, scientific, and regulatory perspectives regarding the use of placebos in cancer clinical trials. J Clin Oncol (2008) 1.71
Pay for performance at the tipping point. N Engl J Med (2007) 1.71
Will physicians lead on controlling health care costs? JAMA (2013) 1.71
Use of colony-stimulating factors with chemotherapy: opportunities for cost savings and improved outcomes. J Natl Cancer Inst (2011) 1.71
Revisiting readmissions--changing the incentives for shared accountability. N Engl J Med (2009) 1.70
Health care reform and cost control. N Engl J Med (2010) 1.66
Frequency, type, and monetary value of financial conflicts of interest in cancer clinical research. J Clin Oncol (2007) 1.65
Ethics. The ethics of international research with abandoned children. Science (2007) 1.65
Measuring efficiency: the association of hospital costs and quality of care. Health Aff (Millwood) (2009) 1.65
Why patients continue to participate in clinical research. Arch Intern Med (2008) 1.62
The OECD Health Care Quality Indicators Project: history and background. Int J Qual Health Care (2006) 1.55
Ending concerns about undue inducement. J Law Med Ethics (2004) 1.55
Analysis of early accountable care organizations defines patient, structural, cost, and quality-of-care characteristics. Health Aff (Millwood) (2014) 1.51
Health care reform: why? What? When? Health Aff (Millwood) (2005) 1.50
Regional ethics organizations for protection of human research participants. Nat Med (2004) 1.48
Can primary care visits reduce hospital utilization among Medicare beneficiaries at the end of life? J Gen Intern Med (2008) 1.47
Improving access to health care: a consensus ethical framework to guide proposals for reform. Hastings Cent Rep (2007) 1.47
Influence of cardiac surgeon report cards on patient referral by cardiologists in New York state after 20 years of public reporting. Circ Cardiovasc Qual Outcomes (2013) 1.46